Public-registry site landscape for NCT07738510, a Myelodysplastic Syndromes study sponsored by Halia Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07738510 (registry record) |
| Sponsor | Halia Therapeutics, Inc. |
| Condition(s) | Myelodysplastic Syndromes; Anemia |
| Phase | PHASE2 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07738510 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →